6MARCH 2024TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharmaceutical manufacturing landscape is ablaze with innovation, adaptability, and a renewed commitment to redefine industry norms. Today, the meteoric rise of technology adoption underscores the need for digitizing and automating manufacturing operations for greater efficiency and safety.An excellent example is the transformative influence of AI, which is driving next-generation pharmaceutical and biomedical research by propelling scientific investigation from descriptive and reactive to prescriptive and predictive, unlocking unprecedented possibilities. In fact, generative AI tools have opened the doors to numerous unexplored ingredients and processes, empowering researchers to discover over 2.2 million new chemical structures.As the pharma manufacturing industry celebrates breakthroughs in vaccine development, obesity management, and gene therapy advancements, pharma operations equipped with AI face the dual challenge of addressing immediate and longer-term hurdles. Navigating the compounding effects of inflation and other factors that influence timely and strategic investments, they must now take a holistic approach to meet deadlines in a compliant and timely manner.With the pharma industry projected to reach a value of USD 863.6 Billion by 2030, the journey ahead is set to be a harmonious blend of challenge and exhilaration as organizations navigate uncharted waters with resilience, vision, and an unwavering commitment to positive outcomes for patients and investors alike.This issue of Pharma Tech Outlook Europe showcases pharma manufacturing solutions providers who play a pivotal role in shaping the future of businesses. The edition includes some thought leadership articles from Mattia Wiedemeier, Commercial Director at Schedio; Furio Zedde, Business Development Manager, and Partner at Italvacuum; Erik Lemay, Head of Global External Manufacturing at Servier; and Dana Edwards, Vice President for Patient Access and Strategic Engagement at UBC.We hope these valuable insights from industry leaders featured in this edition will assist you in making informed decisions for your businesses.Unlocking Innovative Manufacturing Competencies for a Healthier FutureCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MARCH - 11 - 2024 Vol 09 - Issue 17 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:TECH OUTLOOKTECH OUTLOOKCelestial Jordan
< Page 5 | Page 7 >